Genotypic diversity of resistant Mycobacterium tuberculosis strains isolated from tuberculosis patients in East Azerbaijan center by MIRU-VNTR

Subject Areas : Molecular Microbiology

Ali Afaghi-Garaaleki ¹ (PhD, Department of Microbiology Science and Research Branch, Islamic Azad University, Fars, Iran.)
Seyyedreza Moaddab ² (Associate Professor, Department of Laboratory Sciences, Paramedical Faculty, Tabriz University of Medical Sciences, Tabriz, Iran.)
Mojtaba Darboei ³ (Assistant Professor, Department of Microbiology Science and Research Branch, Islamic Azad University, Fars, Iran.)
Khalil Ansarin ⁴ (Professor, Tuberculosis and Lung Disease Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.)
Shahram Hanifian ⁵ (Assistant Professor, Department of Food Science and Technology, Tabriz Branch, Islamic Azad University, Tabriz, Iran.)

Received: 2018-07-29 Accepted : 2018-08-29 Published : 2019-02-20

Keywords: Tuberculosis, Genotyping, Multidrug resistance, MIRU-VNTR, Genotypic family,

Abstract :

Background & Objectives: Tuberculosis has become one of the most serious diseases due to theincreased prevalence of resistance. To control the disease, tuberculosis molecular epidemiological studies are important in determining the genetic diversity of strains circulating in communities. The aim of this study was to investigate the molecular epidemiology of drug-resistant tuberculosis among patients in Iran and Azerbaijan.   Materials & Methods: The isolates from tuberculosis patients of the Azerbaijan Republic andTabriz were studied from March 2014 to March 2015. All isolates were identified as Mycobacterium tuberculosis complex by biochemical methods and drug susceptibility testing against isoniazid, rifampicin, streptomycin, and ethambutol was performed by proportional method. Following DNA extraction, each MIRU locus was amplified individually to determine their repeat numbers as compared to H37Rv standard strain. Finally, genotyping was performed according to the repeat numbers of subsets of 15 studied loci using the MIRU-VNTRplus reference website.   Results: Totally of 119 obtained isolates, resistance to at least one drug of the first line of anti-TB drugs and multidrug resistance were observed as 27.73 and 6.72 percent, respectively. Cameron, UgandaӀ, UgandaӀӀ, LAM, TUR, Dehli/CAS, Bovis, Beijing, NEW-1 and H37Rv were among genotypic families which were determined.   Conclusion: According to the results of this study, the rate and pattern of drug resistance andgenotypic families are different among the people of Tabriz and Azerbaijan, but the indicators were more diverse in Azerbaijan as compared to Tabriz.

References:

1. WHO, Drug-resistant TB surveillance & response, supplement global tuberculosis report 2014.
   Available at: http://www.who.int/tb/publications/global_report/gtbr14_supplement_web_v3.pdf.
   2. WHO, World Health Organization 2017. Global tuberculosis report. Available at: http://
   apps.who.int/iris/bitstream/handle/10665/259366/9789241565516-eng.pdf;jsessionid.
   3. Tavakoli A. Incidence and prevalence of tuberculosis in Iran and neighboring countries. Zahedan J
   Res Med Sci. 2017; 19(7): e9238.
   4. Hajimiri ES, Masoomi M, Ebrahimzadeh N, Fateh A, Hadizadeh Tasbiti A, Rahimi Jamnani F,
   Siadat SD. High prevalence of Mycobacterium tuberculosis mixed infection in the capital of
   moderate tuberculosis incidence country. Microb Pathog. 2016; 93: 213-218.
   5. Metanat M, Mood BS, Shahreki S, Dawoudi SH. Prevalence of multidrug-resistant and extensively
   drug-resistant tuberculosis in patients with pulmonary tuberculosis in Zahedan. southeastern Iran.
   Iran Red Crescent Medical J. 2012; 14(1): 53-55.
   
   6. Asgharzadeh M, Samadi Kafil H, Pour-Ostadi M, Ghorghanlu S. The role of Azeri patients in
   transmission of tuberculosis to East Azerbaijan, Iran. Analyt Res Clin Med. 2015; 3(2): 94-98.
   7. Ju Chin P, Jou TR. A modified automated high-throughput mycobacterial interspersed repetitive
   unit method for genotyping Mycobacterium tuberculosis. Diagn Microbiol Infect Dis. 2005; 53:
   325-327.
   8. Mathema B, Kurepina NE, Bifani PJ, Kreiswirth BN. Molecular epidemiology of tuberculosis:
   Current insights. Clin Microbiol Rev. 2006; 19(4): 658-685.
   9. Velayati AA, Farnia P, Mozafari M, Malekshahian D, Farahbod AM, Seif S, Mirsaeidi M.
   Identification and genotyping of Mycobacterium tuberculosis isolated from water and soil samples
   of a Metropolitan City. Chest. 2015; 147(4): 109-114.
   10. Supply P, Lesjean S, Savine E, Kremer K, Van Soolingen D, Locht C. Automated high-throughput
   genotyping for study of global epidemiology of Mycobacterium tuberculosis based on mycobacterial
   interspersed repetitive units. J Clin Microbiol. 2001; 39(10): 3563-3571.
   11. Romano MI, Amadio A, Bigi F, Klepp L, Etchechoury I, Llana MN, Cataldi A. Further analysis of
   VNTR and MIRU in the genome of Mycobacterium avium complex, and application to molecular
   epidemiology of isolates from South America. Vet Microbiol. 2005; 110(3-4): 221-237.
   12. Mathema B, Kurepina NE, Bifani PJ, Kreiswirth BN. Molecular epidemiology of tuberculosis:
   Current insights. Clin Microbiol Rev. 2006; 19(4): 658-685.
   13. Won Yun K, Ju Song E, Eun Choi G, Kyung Hwang I, Yup Lee E, Chang CL. Strain typing of
   Mycobacterium tuberculosis isolates from Korea by mycobacterial interspersed repetitive
   units-variable number of tandem repeats. Korean J Lab Med. 2009; 29: 314-319.
   14. Yana J, Joub, Chien Koc W, Jong Wud J, Lin Yanga M, Mo Chen H. The use of variable-number
   tandem-repeat mycobacterial interspersed repetitive unit typing to identify laboratory crosscontamination with Mycobacterium tuberculosis. Diagn Microbiol Infect Dis. 2005; 52: 21-28.
   15. Rafi A, Moaddab SR. Principles of mycobacteriology. Tabriz, Iran. Soutodeh, 2003. [In Persian]
   16. Rieder HL, Chonde TM, Myking H, Urbanczik R, Laszlo A, Kim SJ, Deun AV, Trébucq A. The
   public health service national tuberculosis reference laboratory and the national laboratory network.
   Paris, France. International Union Against Tuberculosis and Lung Disease (IUATLD). 1998.
   17. Somerville W, Thibert L, Schwartzman K, Behr MA. Extraction of Mycobacterium tuberculosis
   DNA: A question of containment. J Clin Microbiol. 2005; 43(6): 2996-2997.
   18. Afaghi-Gharamaleki A, Moaddab S, Darbouy M, Ansarin K, Hanifian S. Determining the risk of
   intra-community transmission of tuberculosis in the northwest of Iran though 15 loci MIRU-VNTR
   typing. Eur J Microbiol Immunol. 2017; 7(1): 46-54.
   19. Supply P, Allix C, Lesjean S, Cardoso-Oelemann M, Ru¨sch-Gerdes S, Willery E, Savine E, Haas
   PD, Deutekom HV, Roring S, Bifani P, Kurepina N, Kreiswirth B, Sola C, Rastogi N, Vatin V,
   Gutierrez MC, Fauville M, Niemann S, Skuce R, Kremer K, Locht C, Soolingen DV. Proposal for
   standardization of optimized mycobacterial interspersed repetitive unit–variable-number tandem
   repeat typing of Mycobacterium tuberculosis. J Clin Microbiol. 2006; 44(12): 4498-4510.
   20. Allix-Be´guec C, Harmsen D, Weniger T, Supply P, Niemann S. Evaluation and strategy for use of
   MIRU-VNTRplus, a multifunctional database for online analysis of genotyping data and
   
   phylogenetic identification of Mycobacterium tuberculosis complex isolates. J Clin Microbiol.
   2008; 46(8): 2692-2699.
   21. Saitou N, Nei M. The neighbor-joining method: a new method for reconstructing phylogenetic
   trees. Mol Biol Evol. 1987; 4: 406-425.
   22. Monteserin J, Camacho M, Barrera L, Palomino JC, Ritacco V, Martin A. Genotypes of
   Mycobacterium tuberculosis in patients at risk of drug resistance in Bolivia. Infect Genet Evol.
   2013; 17: 195-201.
   23. Asgharzadeh M, Nahaei MR, Rafi A. Identification of Ethambotol-resistant strains of
   Mycobacterium tuberculosis by MAS-PCR and its comparing with proportional method. J
   Mazandaran Univ Med Sci. 2007; 17(5): 50-56. [In Persian]
   24. Roshdi Maleki M, Moaadab SR. Drug susceptibility of Mycobacterium tuberculosis strains to
   primary and secondary drugs in Tabriz. Iranian Med J Microbiol. 2009; 1: 18- 24. [In Persian]
   25. Naserpour FT, Naderi M, Mohagheghi Far AH, Oskoui Oweisi H, Sharifi-Moud B. Drug
   resistance of Mycobacterium tuberculosis strains isolated from patients with pulmonary
   tuberculosis in South Eastern of Iran. J Med Sci. 2006; 6(2): 275-278.
   26. Pourakbari B, Mamishi S, Mohammadzadeh M, Mahmoudi S. First-line anti-tubercular drug
   resistance of Mycobacterium tuberculosis in Iran: A systematic review. Front Microb. 2016; 7:
   1-13. doi: 10.3389/fmicb.2016.01139.
   27. Metanat M, Sharifi-Mood B, Shahreki S, Dawoudi SH. Prevalence of multidrug-resistant and
   extensively drug-resistant tuberculosis in patients with pulmonary tuberculosis in Zahedan,
   Southeastern Iran. Iran Red Crescent Med J. 2012; 14(1): 53-55.
   28. Merza MA, Farnia P, Tabarsi P, Khazampour M, Masjedi MR, Velayati AA. Anti-tuberculosis
   drug resistance and associated risk factors in a tertiary level TB centre in Iran: a retrospective
   analysis. J Infect Dev Ctries. 2011; 5(7): 511-519.
   29. Punpanich Vandepitte W, Rattanasataporn R, Treeratweeraphong V. Drug-resistant tuberculosis
   among urban Thai children: A 10-year review. Southeast Asian J Trop Med Public Health. 2015;
   46(5): 892-900.
   30. WHO. 2015. Global tuberculosis report. Availabe at: www.who.int/iris/
   bitstream/10665/191102/1/9789241565059_eng.pdf?ua.
   31. Sharma SK, Sethi S, Mewara A, Meharwal S, Jindal S, Sharma M, Katoch V. Genetic
   polimorphisms among Mycobacterium tuberculosis isolates from patients with pulmonary
   tuberculosis in Northern India. Southeast Asian J Trop Med Public Health. 2012; 43(5):
   1161-1168.
   32. Alikhanova N, Akhundova I, Seyfaddinova M, Mammadbayov E, Mirtskulava V, Rusch-Gerdes
   S, Bayramov R, Suleymanova J, Kremer K, Dadu A, Acosta D, Acosta AD, Dara M. First national
   survey of anti-tuberculosis drug resistance in Azerbaijan and risk factors analysis. Public Health
   Action. 2014; 4(2): S17–23.
   33. Azimi T, Nasiri M J, Zamani S, Hashemi A, Goudarzi H, Imani Fooladi AA, Feizabadi MM,
   Fallah F. High genetic diversity among Mycobacterium tuberculosis strains in Tehran, Iran J Clin
   Tuberc Other Mycobact Dis. 2018; 11: 1-6.
   
   34. Haeili M, Darban-Sarokhalil D, Fooladi AA, Javadpour S, Hashemi A, Siavoshi F, Feizabadi
   MM. Spoligotyping and drug resistance patterns of Mycobacterium tuberculosis
   isolates from five provinces of Iran. Microbiol Open. 2013; 2(6): 988-996.
   35. Hoffner S, Sahebi L, Ansarin K, Sabour S, Mohajeri P. Mycobacterium tuberculosis of the
   Beijing genotype in Iran and the WHO Eastern Mediterranean Region: A meta-analysis. Microb
   Drug Resist. 2017; 24(6): 693-698.
   36. Teixeira Dantas NG, Noel Suffys P, Carvalho WS, Magdinier Gomes H, Refregier G, Sola C,
   Kireopori Gomgnimbou M. Genetic diversity and molecular epidemiology of multidrug-resistant
   Mycobacterium tuberculosis in Minas Gerais State, Brazil. BMC Infect Dis. 2015; 15: 306-316.
   37. Liu Y, Tian M, Wang X, Wei R, Xing Q, Ma T, Jiang X, Li W, Zhang Z, Xue Y, Zhang X,
   Wang W, Wang T, Hong F, Zhang J, Wang S, Li C. Genotypic diversity analysis of
   Mycobacterium tuberculosis strains collected from Beijing in 2009, using spoligotyping and
   VNTR typing. PLoS One. 2014; 9(9): 1067-1087.